Market Overview

Charles River Labs Closes Purchase of Majority Ownership of Vital River

Related CRL
Benzinga's Top Upgrades
Charles River Laboratories, AstraZeneca Renew Strategic Partnership Agreement

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed its acquisition of a 75% ownership of Vital River, the premier commercial provider of research models and related services in China, and a licensee of Charles River for the last ten years.

Posted-In: News M&A


Related Articles (CRL)

View Comments and Join the Discussion!

Get Benzinga's Newsletters